Efluelda Tetra

Efluelda Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is suitable for intramuscular or subcutaneous use and is manufactured by Sanofi Winthrop Industrie.

Efluelda Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the B/Michigan/01/2021 virus. This vaccine is typically administered to individuals seeking protection against seasonal flu strains. It is important to consult with a healthcare provider to determine if this vaccine is appropriate for your specific needs.

Common effects of Efluelda Tetra may include mild soreness or redness at the injection site. Some individuals may experience temporary discomfort, fatigue, or low-grade fever following vaccination. These effects are generally mild and short-lived.

Efluelda Tetra should be handled and stored according to the manufacturer's guidelines to maintain its efficacy. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of the vaccine components should exercise caution. Always consult a healthcare provider before receiving this vaccine.

Efluelda Tetra may interact with certain medications or health conditions. It is important to inform your healthcare provider about any ongoing treatments or health issues before receiving this vaccine. Specific interactions with alcohol or other substances are not typically reported, but general health precautions should be followed.